Thermo Fisher Scientific Total Current Liabilities

Thermo Fisher Scientific (TN8.DE) currently reports a total current liabilities of $14B as of September 2026. That compares with $15B in the prior-year period — down 4.8% year over year. Use the charts on this page to explore Thermo Fisher Scientific's total current liabilities history and peer comparisons.

Thermo Fisher Scientific's total current liabilities decreased from $15B to $14B — a 4.8% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Thermo Fisher Scientific reported $14B in total current liabilities as of September 2026. That compares with $15B in the prior-year period — down 4.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $14B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Thermo Fisher Scientific, and consider following TN8.DE for alerts when major investors trade the stock.

Thermo Fisher Scientific is classified in the Healthcare sector. On total current liabilities, it currently shows $14B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TN8.DE with unrelated industries.